Clinical Research Directory
Browse clinical research sites, groups, and studies.
Local Antibiotic Delivery for Community Acquired Pneumonia
Sponsor: Copenhagen Respiratory Research
Summary
A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without pre-existing lung disease.
Official title: Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot Study (LANDCAP1)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2025-03-04
Completion Date
2028-09-01
Last Updated
2025-03-10
Healthy Volunteers
No
Conditions
Interventions
Levofloxacin
Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.
Placebo
Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.